Patents Assigned to REGENERA PHARMA LTD.
  • Compositions comprising triterpenoids and uses thereof for treating optic neuropathy
    Patent number: 11207333
    Abstract: The invention relates to compositions and formulations comprising at least one triterpenoic acid and at least one neutral triterpenoid and uses thereof for treating optic neuropathy conditions.
    Type: Grant
    Filed: September 7, 2017
    Date of Patent: December 28, 2021
    Assignee: REGENERA PHARMA LTD.
    Inventors: Zadik Hazan, Andre C. B. Lucassen, Konstantin Adamsky
  • Compositions comprising triterpenoids
    Patent number: 11173164
    Abstract: The invention relates to compositions and formulations comprising at least one triterpenoic acid and at least one neutral triterpenoid and uses thereof for treating for use in treating a condition selected from Alzheimer's disease (AD), Parkinson's Diseases (PD) and vascular dementia (VD).
    Type: Grant
    Filed: January 23, 2020
    Date of Patent: November 16, 2021
    Assignee: REGENERA PHARMA LTD.
    Inventors: Zadik Hazan, Konstantin Adamsky, Andre C. B. Lucassen, Nurit Novak
  • Compositions comprising triterpenoids
    Patent number: 11083736
    Abstract: The invention relates to compositions and formulations comprising at least one triterpenoic acid and at least one neutral triterpenoid and uses thereof for treating stroke or trauma and side effects related thereto.
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: August 10, 2021
    Assignee: REGENERA PHARMA LTD.
    Inventors: Zadik Hazan, Konstantin Adamsky, Andre C. B. Lucassen, Nurit Novak
  • Use of isolated fractions of mastic gum for treating optic neuropathy
    Patent number: 11000562
    Abstract: The invention relates to therapeutic uses of isolated fractions of mastic gum for treating optic neuropathy. More particularly, the invention relates to methods of treating optic neuropathy conditions using compositions comprising isolated fractions of mastic gum.
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: May 11, 2021
    Assignee: REGENERA PHARMA LTD.
    Inventors: Zadik Hazan, Konstantin Adamsky, Andre C. B. Lucassen
  • Compositions of polymeric myrcene
    Patent number: 10806763
    Abstract: Compositions and formulations comprising polymeric myrcene. More particularly, the invention relates to compositions comprising an isolated fraction of polymeric myrcene in a hydrophobic carrier and formulations which maintain the biological activity of the active polymer.
    Type: Grant
    Filed: April 23, 2019
    Date of Patent: October 20, 2020
    Assignee: REGENERA PHARMA LTD.
    Inventors: Zadik Hazan, Shimon Amselem
  • Compositions comprising acidic extracts of mastic gum and uses thereof for treating optic neuropathy
    Patent number: 10751347
    Abstract: The invention relates to compositions and formulations comprising isolated acidic fraction of mastic gum and uses thereof for treating optic neuropathy conditions.
    Type: Grant
    Filed: September 7, 2017
    Date of Patent: August 25, 2020
    Assignee: REGENERA PHARMA LTD.
    Inventors: Zadik Hazan, Andre C. B. Lucassen, Konstantin Adamsky
  • COMPOSITIONS COMPRISING TRITERPENOIDS
    Publication number: 20200155569
    Abstract: The invention relates to compositions and formulations comprising at least one triterpenoic acid and at least one neutral triterpenoid and uses thereof for treating for use in treating a condition selected from Alzheimer's disease (AD), Parkinson's Diseases (PD) and vascular dementia (VD).
    Type: Application
    Filed: January 23, 2020
    Publication date: May 21, 2020
    Applicant: REGENERA PHARMA LTD.
    Inventors: Zadik HAZAN, Konstantin ADAMSKY, Andre C. B. LUCASSEN, Nurit NOVAK
  • Compositions comprising triterpenoids
    Patent number: 10588911
    Abstract: The invention relates to compositions and formulations comprising at least one triterpenoic acid and at least one neutral triterpenoid and uses thereof for treating for use in treating a condition selected from Alzheimer's disease (AD), Parkinson's Diseases (PD) and vascular dementia (VD).
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: March 17, 2020
    Assignee: REGENERA PHARMA LTD.
    Inventors: Zadik Hazan, Konstantin Adamsky, Andre C. B. Lucassen, Nurit Novak
  • Compositions comprising acidic extracts of mastic gum
    Patent number: 10561670
    Abstract: The invention relates to compositions and formulations comprising isolated acidic fraction of mastic gum and uses thereof for treating impaired neurological functions as well as wound and tissue repair.
    Type: Grant
    Filed: November 14, 2018
    Date of Patent: February 18, 2020
    Assignee: REGENERA PHARMA LTD.
    Inventors: Zadik Hazan, Andre C. B. Lucassen
  • COMPOSITIONS COMPRISING TRITERPENOIDS
    Publication number: 20190314389
    Abstract: The invention relates to compositions and formulations comprising at least one triterpenoic acid and at least one neutral triterpenoid and uses thereof for treating stroke or trauma and side effects related thereto.
    Type: Application
    Filed: June 25, 2019
    Publication date: October 17, 2019
    Applicant: REGENERA PHARMA LTD.
    Inventors: Zadik HAZAN, Konstantin ADAMSKY, Andre C. B. LUCASSEN, Nurit NOVAK
  • COMPOSTIONS OF POLYMERIC MYRCENE
    Publication number: 20190255132
    Abstract: Compositions and formulations comprising polymeric myrcene. More particularly, the invention relates to compositions comprising an isolated fraction of polymeric myrcene in a hydrophobic carrier and formulations which maintain the biological activity of the active polymer.
    Type: Application
    Filed: April 23, 2019
    Publication date: August 22, 2019
    Applicant: REGENERA PHARMA LTD.
    Inventors: Zadik HAZAN, Shimon AMSELEM
  • COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM AND USES THEREOF FOR TREATING OPTIC NEUROPATHY
    Publication number: 20190224216
    Abstract: The invention relates to compositions and formulations comprising isolated acidic fraction of mastic gum and uses thereof for treating optic neuropathy conditions.
    Type: Application
    Filed: September 7, 2017
    Publication date: July 25, 2019
    Applicant: REGENERA PHARMA LTD.
    Inventors: Zadik HAZAN, Andre C. B. LUCASSEN, Konstantin ADAMSKY
  • COMPOSITIONS COMPRISING TRITERPENOIDS AND USES THEREOF FOR TREATING OPTIC NEUROPATHY
    Publication number: 20190224217
    Abstract: The invention relates to compositions and formulations comprising at least one triterpenoic acid and at least one neutral triterpenoid and uses thereof for treating optic neuropathy conditions.
    Type: Application
    Filed: September 7, 2017
    Publication date: July 25, 2019
    Applicant: REGENERA PHARMA LTD.
    Inventors: Zadik HAZAN, Andre C. B. LUCASSEN, Konstantin ADAMSKY
  • COMPOSITIONS COMPRISING TRITERPENOIDS
    Publication number: 20190209582
    Abstract: The invention relates to compositions and formulations comprising at least one triterpenoic acid and at least one neutral triterpenoid and uses thereof for treating for use in treating a condition selected from Alzheimer's disease (AD), Parkinson's Diseases (PD) and vascular dementia (VD).
    Type: Application
    Filed: March 20, 2019
    Publication date: July 11, 2019
    Applicant: REGENERA PHARMA LTD.
    Inventors: Zadik HAZAN, Konstantin ADAMSKY, Andre C. B. LUCASSEN, Nurit NOVAK
  • THERAPEUTIC USES OF MASTIC GUM FRACTIONS
    Publication number: 20190192594
    Abstract: The invention relates to therapeutic uses of gum mastic, and compounds found therein including polymeric myrcene. More particularly, the invention relates to methods of treating impaired neurological function using compositions comprising polymeric myrcene.
    Type: Application
    Filed: February 27, 2019
    Publication date: June 27, 2019
    Applicant: REGENERA PHARMA LTD.
    Inventor: Zadik HAZAN
  • Compositions of polymeric myrcene
    Patent number: 10307449
    Abstract: Compositions and formulations comprising polymeric myrcene. More particularly, the invention relates to compositions comprising an isolated fraction of polymeric myrcene in a hydrophobic carrier and formulations which maintain the biological activity of the active polymer.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: June 4, 2019
    Assignee: REGENERA PHARMA LTD.
    Inventors: Zadik Hazan, Shimon Amselem
  • Compositions comprising triterpenoids
    Patent number: 10285996
    Abstract: The invention relates to compositions and formulations comprising at least one triterpenoic acid and at least one neutral triterpenoid and uses thereof for treating for use in treating a condition selected from Alzheimer's disease (AD), Parkinson's Diseases (PD) and vascular dementia (VD).
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: May 14, 2019
    Assignee: REGENERA PHARMA LTD.
    Inventors: Zadik Hazan, Konstantin Adamsky, Andre C. B. Lucassen, Nurit Novak
  • Therapeutic uses of mastic gum fractions
    Patent number: 10251923
    Abstract: The invention relates to therapeutic uses of gum mastic, and compounds found therein including polymeric myrcene. More particularly, the invention relates to methods of treating impaired neurological function using compositions comprising polymeric myrcene.
    Type: Grant
    Filed: May 13, 2016
    Date of Patent: April 9, 2019
    Assignee: REGENERA PHARMA LTD.
    Inventor: Zadik Hazan
  • COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM
    Publication number: 20190076444
    Abstract: The invention relates to compositions and formulations comprising isolated acidic fraction of mastic gum and uses thereof for treating impaired neurological functions as well as wound and tissue repair.
    Type: Application
    Filed: November 14, 2018
    Publication date: March 14, 2019
    Applicant: REGENERA PHARMA LTD.
    Inventors: Zadik HAZAN, Andre C. B. LUCASSEN
  • Compositions comprising acidic extracts of mastic gum
    Patent number: 10159680
    Abstract: The invention relates to compositions and formulations comprising isolated acidic fraction of mastic gum and uses thereof for treating impaired neurological functions as well as wound and tissue repair.
    Type: Grant
    Filed: August 15, 2017
    Date of Patent: December 25, 2018
    Assignee: REGENERA PHARMA LTD.
    Inventors: Zadik Hazan, Andre C. B. Lucassen